Skip to main content
. Author manuscript; available in PMC: 2017 Jun 15.
Published in final edited form as: Biometrics. 2016 Sep 6;73(2):378–390. doi: 10.1111/biom.12576

Table 1.

Sample sizes of SMARTer to achieve the same efficiency as SMART with 100 subjects for comparing two DTRs with different first stage treatments

α 0 0.2 0.4 0.5 0.6 0.8
SMARTera β = 0.5
n m n m n m n m n m n m
γ = 0.5 100 50 92 46 91 46 92 46 93 46 96 48
γ = 1 125 62 109 54 102 51 100 50 99 50 99 49
γ = 2 150 75 125 62 112 56 108 54 105 53 102 51
β = 1
γ = 0.5 67 67 73 73 80 80 83 83 87 87 93 93
γ = 1 75 75 80 80 85 85 88 88 90 90 95 95
γ = 2 83 83 87 87 90 90 92 92 93 93 97 97
β = 2
γ = 0.5 50 100 61 122 72 143 77 153 82 163 91 182
γ = 1 50 100 62 124 73 145 78 155 82 165 91 183
γ = 2 50 100 62 125 73 147 78 157 83 166 92 184
SMART-misb NA 500 250 200 167 125
a

Sample sizes for SMARTer are to achieve same efficiency as a SMART trial with 100 patients and in an ideal case of no dropout. n is the sample size for the SMART group, m is the sample size for the enrichment group; β = m/n is the ratio of sample size between enrichment and SMART group; α is the completion rate; γ is ratio of within- and between-stratum variance.

b

SMART-mis is the sample size for a SMART accounting for the dropout rate of 1 − α in the second stage in the design, that is, 100.